← All organizations

Bay Area Retina Associates

Academic/Hospital

Also known as: Bay Area Retina Associates | Physician | Roger Goldberg, M.D., MBA | Subhransu K. Ray, M.D., Ph.D.

Highest phase reached

Phase 4

First clinical trial

Aug 1, 2006

Last known activity

Nov 30, 2023

Timeline

No events for the selected filters.

Drugs by trial phase (15 distinct, 12 trials)

Phase 2 (3 own, 0 via acquisition)

Other trials (5 own, 0 via acquisition)

Indications

Recent trials (21)

  • NCT06100510Study directorPhase 4Nov 30, 2023
  • NCT05440968Overall official - principal investigatorN/AJun 30, 2022
  • NCT05440968OfficialN/AJun 30, 2022
  • NCT04530539Overall official - principal investigatorN/ASep 18, 2020
  • NCT04529512Overall official - principal investigatorPhase 4Aug 31, 2020
  • NCT04205916Overall official - principal investigatorPhase 4Nov 4, 2019
  • NCT04130464Overall official - principal investigatorPhase 4Sep 30, 2019
  • NCT03832179Reponsible party - principal investigatorPhase 4Nov 15, 2018
  • NCT03832179Overall official - principal investigatorPhase 4Nov 15, 2018
  • NCT03832179Lead sponsorPhase 4Nov 15, 2018
  • NCT03817645Overall official - principal investigatorN/AMar 9, 2018
  • NCT02751151Overall official - principal investigatorN/AFeb 29, 2016
  • NCT02354170Sponsor investigatorPhase 2Jan 1, 2015
  • NCT02354170Overall official - principal investigatorPhase 2Jan 1, 2015
  • NCT02354170Lead sponsorPhase 2Jan 1, 2015

Details

Last known activity
Nov 30, 2023